November 11, 2025 a 07:43 am

RMD: Fundamental Ratio Analysis - ResMed Inc.

ResMed Inc. Stock Analysis

ResMed Inc. presents a robust portfolio in the healthcare industry with a focus on sleep and respiratory care. Its recent performance indicates a stable fundamental rating supported by strong equity returns. However, its debt-to-equity and price evaluations suggest areas for improvement, warranting close investor attention.

Fundamentals Rating

The company's fundamental analysis highlights a strong return on equity and assets, though with lower scores in debt-to-equity and valuation metrics.

CategoryScoreVisualization
Discounted Cash Flow4
Return on Equity5
Return on Assets5
Debt to Equity2
Price to Earnings2
Price to Book1

Historical Rating

Historical scores show consistency over time, reflecting sustained fundamental strength.

DateOverall ScoreDiscounted Cash FlowReturn on EquityReturn on AssetsDebt to EquityPrice to EarningsPrice to Book
2025-11-103455221
Previous0455221

Analyst Price Targets

Analyst estimates reveal a stable market view with the median price target aligning well with consensus recommendations.

HighLowMedianConsensus
305280299.5296
ResMed Stock Chart

Analyst Sentiment

The stock maintains a promising sentiment with a strong bias towards 'Buy' recommendations.

RecommendationNumberDistribution
Strong Buy0
Buy17
Hold12
Sell5
Strong Sell0

Conclusion

ResMed Inc. shows promising potential in the healthcare sector with robust returns on investment metrics. However, its valuation metrics and debt levels suggest some caution. The company's consistent historical performance adds confidence, yet careful monitoring of pricing strategies and debt management is advised. Analyst sentiment remains favorable, reinforcing its attractiveness as a strong long-term investment opportunity.